The impact of ponatinib versus allogeneic stem cell transplant (SCT) on outcomes in patients with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL) with the T315I mutation Meeting Abstract
| Authors: | Nicolini, F. E.; Basak, G. W.; Kim, D. W.; Olavarria, E.; Pinilla-Ibarz, J.; Apperley, J. F.; Hughes, T. P.; Niederwieser, D.; Mauro, M. J.; Chuah, C.; Hochhaus, A.; Martinelli, G.; DerSarkissian, M.; Kageleiry, A.; Yang, M.; Huang, H.; McGarry, L. J.; Kantarjian, H. M.; Cortes, J. E. |
| Abstract Title: | The impact of ponatinib versus allogeneic stem cell transplant (SCT) on outcomes in patients with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL) with the T315I mutation |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019001226 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.480.480 |
| Notes: | Meeting Abstract: 480 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
